Home » Israeli Firm Leads Investment in COVID-19 Vaccine
Israeli Firm Leads Investment in COVID-19 Vaccine
MigVax, an affiliate of the Migal Galilee Research Institute in Israel, is developing a vaccine candidate for COVID-19.
The company previously developed a vaccine against infectious bronchitis virus, a coronavirus strain that causes bronchial disease in poultry.
The Israel-based OurCrowd is leading a $12 million investment in a human vaccine development program.
Upcoming Events
-
18Jul
-
21Oct